Risk of anaphylaxis after <scp>COVID</scp>‐19 vaccination in South Korea: A nationwide <scp>self‐controlled</scp> case series analysis-Reference-Cited by-同舟云学术

Risk of anaphylaxis after COVID‐19 vaccination in South Korea: A nationwide self‐controlled case series analysis

Published:2023-12-12 Issue: Volume: Page:
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Yoon Dongwon¹²,Kim Ju Hwan¹²,Jeong Han Eol¹²^ORCID,Ko Hwa Yeon¹,Kim Sung‐Ryeol³,Shin Ju‐Young¹²⁴^ORCID,

Affiliation:

1. School of Pharmacy Sungkyunkwan University Suwon South Korea

2. Department of Biohealth Regulatory Science Sungkyunkwan University Suwon South Korea

3. Division of Pulmonology Allergy and Critical Care Medicine Department of Internal Medicine Yongin Severance Hospital Yonsei University College of Medicine Yongin South Korea

4. Department of Clinical Research Design & Evaluation Samsung Advanced Institute for Health Sciences & Technology Sungkyunkwan University Seoul South Korea

Funder

Korea Disease Control and Prevention Agency

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15975

Reference6 articles.

1. Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives

2. Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper

3. Validity of hospital ICD‐10‐GM codes to identify anaphylaxis

4. The self-controlled case series method and covid-19

5. Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ad26.COV2-S;Reactions Weekly;2024-05-18

2. Drug hypersensitivity: Past, present and future;Allergy;2024-02-16